115 results

• GLP-1 Vision Loss Risks Extend Beyond Type 2 Diabetics and Ozempic Users, Study Warns

  August 6, 2025

  Irvin Jackson

  New research suggests that vision problems are not restricted to just Ozempic, but may be a risk faced by all GLP-1 medication users.

• Lawsuit Indicates Mounjaro Caused Gastroparesis, Severe Metabolic Acidosis Injuries

  July 29, 2025

  Irvin Jackson

  A Mounjaro lawsuit claims an Ohio woman suffered severe injuries due to a lack of warnings about the risks of stomach paralysis.

• Pancreatitis Risks From Ozempic, Mounjaro Being Investigated by U.K. Regulators

  July 15, 2025

  Irvin Jackson

  U.K. health regulators are urging users of drugs like Ozempic and Mounjaro to report cases of acute pancreatitis as part of an ongoing genetic investigation.

• NAION Ozempic Lawsuit Filed After User’s Eye Suffers 85% Vision Loss

  July 10, 2025

  Irvin Jackson

  Novo Nordisk is facing a lawsuit alleging it failed to adequately warn about the risk of vision loss from Ozempic, including cases of NAION (non-arteritic anterior ischemic optic neuropathy).

• Ozempic Vision Risks Could Also Include Age-Related Macular Degeneration: Study

  June 23, 2025

  Irvin Jackson

  A new study links the use of Ozempic and Wegovy to an increased risk of age-related macular degeneration that could cause vision loss.

• Centralization of Ozempic, Wegovy NAION Lawsuits Sought in New Jersey State Court

  June 18, 2025

  Irvin Jackson

  At least 21 Ozempic and Wegovy lawsuits have been filed in New Jersey state court, involving allegations that users were left with vision loss from NAION after using the popular diabetes and weight loss drugs.

• Saxenda, Wegovy Vision Loss Lawsuit Filed Over NAION Diagnosis

  June 13, 2025

  Irvin Jackson

  A Wegovy and Saxenda lawsuit claims that the two weight loss drugs caused a rare eye condition that led to blurred vision as well as vision loss in a woman’s right eye.

• Ozempic NAION Side Effects Result in Vision Loss Warnings by European Regulators

  June 9, 2025

  Irvin Jackson

  European regulators have determined that Ozempic and similar semaglutide-based drugs increase the risk of a rare vision disorder that can cause vision loss and blindness.

• Wegovy Lawsuit Alleges Vision Loss Side Effects Concealed by Novo Nordisk

  May 6, 2025

  Irvin Jackson

  A Wegovy lawsuit claims the weight loss drug's side effects caused him to suffer vision problems after a year of injections.

• More Than a Third of GLP-1 Drug Users Microdose To Avoid Side Effects, Survey Finds

  May 2, 2025

  Irvin Jackson

  Most users of Ozempic and similar drugs say they currently take microdoses of the medications or have done so in the past.